Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127607171 | 12760717 | 1 | I | 20160824 | 20160914 | 20160919 | 20160919 | PER | US-B.I. PHARMACEUTICALS,INC./RIDGEFIELD-2016-BI-60468BP | BOEHRINGER INGELHEIM | 55.19 | YR | M | Y | 0.00000 | 20160920 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127607171 | 12760717 | 1 | PS | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 0.25 MG | N | 22421 | .25 | MG | TABLET | QD | |||||
127607171 | 12760717 | 2 | SS | MIRAPEX | PRAMIPEXOLE DIHYDROCHLORIDE | 1 | Oral | 0.125 MG | N | 22421 | .125 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127607171 | 12760717 | 1 | Restless legs syndrome |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127607171 | 12760717 | Dizziness |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127607171 | 12760717 | 1 | 20160815 | 20160831 | 0 | |
127607171 | 12760717 | 2 | 20160831 | 0 |